جست‌وجوی استاد و پژوهشگر

Barbara M. Grünerمشاهده پروفایل

استاد

• Cancer Metastasis
• Cell Plasticity
• Molecular Oncology
• +۳ مورد دیگر

Barbara M. Grüner is a Professor at the West German Cancer Center within University Hospital Essen, leading the Research Group on Cell Plasticity and Metastasis. Her work focuses on uncovering molecular mechanisms of cancer metastasis and therapeutic resistance using advanced in vivo models and DNA-barcoding technology. Institution: University Hospital Essen Lab Location: WTZ-F R1.001, Hufelandstr. 55, 45147 Essen Contact: barbara.gruener@uk-essen.de Research Interests center on: Molecular basis of cancer cell metastasis Therapeutic intervention strategies Cell plasticity during tumor progression Mechanisms of drug resistance Mitochondrial dynamics in metastatic cells Chromatin accessibility in metastatic gene expression Selected Publications highlight work on proteomic drug analysis (2023), statins in cancer plasticity (2021), mitochondrial vulnerabilities (2020), and chromatin regulators of metastasis (2016). Her lab actively recruits PhD, MD, and Postdoc researchers. Team Members include postdoctoral fellows (Dorsch, Urban, Baginska), PhD students (Conroy, Jung, Martinez Cruz, Munteanu), technicians (Hahn, Meyer), and alumni contributors (Biller, Dujardin).

Joseph D. Kueblerمشاهده پروفایل

دانشیار

• Quality Improvement in Pediatric Cardiology
• Point-of-Care Ultrasound
• Echocardiography in Intensive Care Units
• +۳ مورد دیگر

Joseph D. Kuebler, M.D., M.B.A., is an Associate Professor of Pediatrics at the University of Rochester School of Medicine and Dentistry. He specializes in Pediatric Cardiology and Critical Care Medicine, serving as Medical Director of the Pediatric Cardiac Care Center and Director of Pediatric Critical Care Ultrasound. His board certifications include Pediatric Critical Care and Pediatric Cardiology. Education: MD from Jacobs School of Medicine and Biomedical Sciences (University at Buffalo, 2008) Residency & Fellowship: Pediatrics at Yale New Haven Hospital (2008-2012), Pediatric Cardiology at Boston Children's Hospital/Harvard Medical School (2012-2016), Pediatric Critical Care at University of Rochester Medical Center (2016-2018) Dr. Kuebler's research focuses on quality improvement and outcomes in pediatric cardiology, point-of-care ultrasound, echocardiography in intensive care units, 3-dimensional echocardiography, and nutrition in congenital heart disease. His publications span topics from viral critical illness in infants to advanced cardiac imaging techniques and robotic interventions. Recent trends in his work include collaborative national studies on respiratory syncytial virus (RSV) outcomes (2025), multisystem inflammatory syndrome (MIS-C) protocols (2021), and historical contributions to emergency medicine (2007). Notable awards include the 2023 ICARE Bronze Star for clinical excellence and the 2018 Medical Student Teaching Award. 2023 ICARE Bronze Star 2018 Medical Student Teaching Award Dr. Kuebler leads initiatives in the Pediatric Cardiac Critical Care Consortium (PC4) and integrates ultrasound technology into critical care practices. Though no formal advisees or grants are mentioned, his leadership roles and dual certification highlight his expertise in pediatric cardiac care.

• Clinical Obesity Research
• Adipose Tissue Biology
• Mechanisms of Fat Distribution
• +۴ مورد دیگر

Dr. Pamela Nono Nankam serves as a Post-Doctoral Researcher at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München, located within the University Hospital Leipzig at the University of Leipzig's Faculty of Medicine. She leads research within Matthias Blüher's Clinical Obesity Research Group, focusing on translational approaches to metabolic disorders. Her academic foundation includes: Bachelor and Master of Sciences in Animal Physiology from the University of Dschang, Cameroon PhD in Human Biology from the University of Cape Town, South Africa, supported by NRF-TWAS and DAAD fellowships Dr. Nankam's research centers on adipose tissue dysfunction mechanisms, particularly in lipedema and obesity. She pioneers single-cell/nuclei investigations of human adipose tissue across diverse fat distributions, while identifying novel circulating biomarkers for early disease detection. Her work bridges basic science with clinical applications to develop personalized treatment frameworks. Analysis of her recent publications reveals dominant themes in adipose tissue heterogeneity, with increasing focus on lipedema pathophysiology and ethnic-specific metabolic responses. The integration of single-cell sequencing with clinical phenotyping represents a significant methodological evolution in her research trajectory. Her scientific contributions have earned recognition through: Science Prize Award of the Lipedema Society e.V. (2023) Proof of Concept Award from the Lipedema Foundation (2022) DAAD Research Grant for doctoral studies (2018) NRF-TWAS Doctoral Fellowship (2016) Funding for her work includes an active grant from the Lipedema Foundation (USA) supporting biomarker discovery in lipedema. She maintains strategic collaborations through the German Lipedema Society and European Association for the Study of Diabetes, with research directly informing clinical practice improvements. Within HI-MAG's infrastructure, she directs single-cell genomics workflows for adipose tissue characterization while contributing to the Clinical Obesity Research Group's mission of transforming diagnostic paradigms for metabolic disorders through mechanistic insights.

Tracy Hengمشاهده پروفایل

دانشیار

• Stem Cell Therapy
• Immunology
• Cell Therapy
• +۳ مورد دیگر

Associate Professor Tracy Heng is an academic at Monash University, leading research on overcoming immunological barriers in stem cell therapies. She holds a PhD from Monash University and completed postdoctoral training at Harvard Medical School. Her roles include Laboratory Head in the Department of Anatomy & Developmental Biology and Deputy Head of the Immunity Program at the Monash Biomedicine Discovery Institute. Education: PhD, Monash University (strategies to improve immune function in ageing) Postdoctoral training with Professors Harald von Boehmer, Christophe Benoist, and Diane Mathis (Harvard Medical School, Immunological Genome Project) Research Interests: Understanding immune responses to stem cell transplantation, optimizing cell therapies, and addressing immunological challenges. Key areas include mesenchymal stromal cell apoptosis, lymphoid organ roles in therapy, and macrophage biology. Recent Articles: Focus on apoptosis-driven therapeutic mechanisms, stromal cell interactions with lymph nodes, and cytokine effects on cell survival. Recent work highlights the critical role of apoptosis in therapeutic efficacy and the importance of secondary lymphoid organs in cell therapy. Awards: 2015 Young Tall Poppy Science Award 2016 Metcalf Prize for Stem Cell Research 2016 NHMRC R.D. Wright Fellowship 2011 ARC Postdoctoral (Industry) Fellowship Projects: Leading projects such as 'The mesenchymal stromal cell paradox' (2022–2025) and 'Surface coatings for directed differentiation of iPSCs to T-cells' (2023–2026). Collaborates on initiatives like the ARC Training Centre for Cell and Tissue Engineering Technologies. Labs/Teams: Leads a research group focused on immunological barriers in stem cell therapies within the Monash Biomedicine Discovery Institute.

Stéphanie Huguesمشاهده پروفایل

استاد

• Immunology
• Autoimmunity
• Cancer Immunotherapy
• +۵ مورد دیگر

Prof. Stéphanie Hugues is a Full Professor in the Department of Pathology and Immunology at the University of Geneva (UNIGE) Faculty of Medicine, and currently serves as Vice-Dean for Careers, Equality, Diversity, Inclusion, and Platforms. She holds a PhD in Immunology from the University of Nice (2002) and completed postdoctoral training at the Institut Curie (Paris) and INSERM. Her research focuses on immune tolerance mechanisms mediated by lymphatic endothelial cells (LECs), particularly their roles in autoimmunity and tumor immunity. Key contributions include elucidating MHC-II-dependent antigen presentation pathways in LECs and their impact on T cell regulation. Education: PhD in Immunology, University of Nice, 2002 Postdoctoral training at Institut Curie (2002–2006) and INSERM (2006–2007) Research and teaching position at UNIGE Faculty of Medicine (2007–2010) Research Interests: Mechanisms of immune tolerance via lymphatic endothelial cells Role of LECs in tumor immunity and metastasis inhibition MHC-II antigen presentation pathways in autoimmunity Circadian rhythms in cancer immunotherapy efficacy Recent work highlights the immunoregulatory functions of LECs in tumor microenvironments and their potential as targets for immunotherapy. Her group also investigates how autophagy and oxysterol metabolism modulate autoimmune responses. Scientific Awards: SNSF Fellowship (2010) Advising & Grants: Supervised over 10 doctoral and master’s students, including notable theses on tumor immunology and autoimmune mechanisms. Active in securing research grants focusing on lymphatic endothelium biology and translational immunology. Labs/Teams: Leads the Immunomodulation by Stromal Cells group at the Geneva Centre for Inflammation Research, collaborating with teams investigating T cell tolerance and tumor immunotherapy strategies.

Julia Castleberryمشاهده پروفایل

دانشیار

• Neurological Rehabilitation
• Geriatric Successful Living Strategies
• Falls Prevention
• +۴ مورد دیگر

Julia Castleberry is an Associate Professor of Physical Therapy at Emory & Henry University’s School of Health Sciences. She holds a DHSc from Radford University-Carilion (2021) and has over 30 years of clinical and academic experience in neurology, geriatrics, and oncology. Her work focuses on falls prevention, lymphedema therapy, and stroke rehabilitation. She co-founded the Falls Prevention Center, emphasizing lifespan wellness and community programs. Castleberry serves on numerous professional boards, including the American Physical Therapy Association’s Neurology Section and Brain Injury Services of Southwest Virginia. She is a certified Dementia Practitioner, Lymphedema Therapist, and LSVT-BIG provider. Education: Doctor of Health Science (DHSc), Radford University-Carilion (2021) Transitional Doctor of Physical Therapy (t-DPT), Virginia Commonwealth University (2011) Master of Science in Physical Therapy, Duke University (1993) Bachelor of Science in Biology, Virginia Tech (1990) Research & Professional Contributions: Castleberry leads studies on falls prevention, chronic disease management, and telehealth for veterans with brain injuries. Her funded projects include a study on Appalachian Trail hikers’ health and a longitudinal program for Parkinson’s, MS, and obesity patients. She has authored peer-reviewed articles, presented nationally, and developed educational programs like the CLiC-Wounded Warrior initiative. Teaching & Service: She teaches courses in neuroscience, neuromuscular therapy, and rural health. She chairs curricular committees and interprofessional education initiatives at Emory & Henry. Her roles in professional organizations include leadership in the Virginia Physical Therapy Association and APTA Neurology Section.

Ali Abdollahzadehمشاهده پروفایل

پژوهشگر ارشد

• Medical Image Analysis
• Biophysics
• Diffusion MRI
• +۶ مورد دیگر

Ali Abdollahzadeh is an Academy Research Fellow at the A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, within the Faculty of Health Sciences. His research focuses on medical image analysis and biophysics, particularly in neuroimaging techniques like diffusion MRI and electron microscopy. He develops advanced computational tools for analyzing white matter ultrastructures and neurovascular interactions. Key projects include studying the role of meningeal lymphatics in neuroinflammation and migraine mechanisms, as well as creating open-source software like SproutAngio and gACSON for bioimage informatics. His work bridges biophysics, computational neuroscience, and clinical applications. Recent studies explore axonal remodeling under stress, neurovascular dynamics, and deep learning applications in neurological disease analysis. He collaborates with the Computational Neuroanatomy Lab and Multiscale Imaging Group, advancing interdisciplinary research in brain imaging and neurodegenerative disorders. Publications highlight innovations in segmentation algorithms, 3D imaging techniques, and translational studies linking microscopic findings to clinical outcomes. His research aims to enhance understanding of CNS structure-function relationships and improve diagnostic tools through advanced imaging methodologies.

• Tissue Engineering
• Vascular Biology
• Stem Cell Research
• +۳ مورد دیگر

Geraldine Mitchell is a Clinical Associate Professor in the School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences. Her research focuses on advancing regenerative medicine through tissue engineering and vascular biology, particularly in liver bioengineering, endothelial cell function, and the development of functional vascular networks. She employs interdisciplinary approaches involving stem cells, biomaterials, and in vivo models to address challenges in organoid differentiation, fat graft survival, and adipose-derived progenitor cell potential. Her work explores the role of endothelial cells in modulating organoid development and leverages innovative methods like vascularized bioreactors and porous scaffolds to enhance tissue viability. Key contributions include studies on nitric oxide signaling in stem cell differentiation, epigenetic profiling of adipose-derived progenitors, and the application of microRNAs to understand metabolic disorders. Research interests span liver niche recapitulation, angiogenesis regulation via PI(4,5)P2 pathways, and the integration of biocompatible materials for 3D scaffold vascularization. Collaborations with multidisciplinary teams emphasize translational applications in regenerative medicine and biomedical engineering.

• Cardiovascular Biology
• Endothelial Cell Biology
• Vascular Development
• +۳ مورد دیگر

Dongying Chen, MD, PhD, is an Associate Research Scientist in the Department of Cardiovascular Medicine at the Yale School of Medicine. Her research focuses on endothelial cell biology, vascular development, and the molecular mechanisms regulating cardiovascular systems. She holds a PhD in Cell and Developmental Biology from Thomas Jefferson University and MD from Sun Yat-Sen University of Medical Sciences. Dr. Chen's work explores ECM interactions in aortic arch development, PLCγ signaling in endothelial function, and arterial fate specification during embryogenesis. She collaborates extensively with researchers like Michael Simons and Anne Eichmann on projects involving vascular permeability, tumor immunity, and lipid metabolism. Her recent studies highlight the role of chylomicrons in intestinal lipid absorption and VEGFR2-driven anti-tumor immunity mechanisms. Key research interests include cell-ECM signaling pathways, developmental cardiovascular biology, and translational studies linking endothelial function to disease. Her work bridges developmental biology with clinical applications in cardiovascular medicine, leveraging interdisciplinary approaches to understand vascular pathophysiology.

• Brain Energy Metabolism
• Magnetic Resonance Imaging (MRI)
• Molecular Imaging
• +۵ مورد دیگر

Dr. D. S. Fahmeed Hyder is a Professor of Radiology & Biomedical Imaging and Biomedical Engineering at Yale University, with joint appointments in the Yale School of Medicine. He leads the Magnetic Resonance Research Center (MRRC) and directs the Core Center for Quantitative Neuroscience with Magnetic Resonance (QNMR). His research focuses on brain energy metabolism, developing advanced MRI techniques to study neuronal-glial interactions, metabolic dysfunction biomarkers, and molecular imaging of tumors. He holds over 240 peer-reviewed publications and has secured continuous NIH funding for 25+ years. Education: B.A. in Chemistry (Wabash College, 1990), Ph.D. in Biophysical Chemistry (Yale University, 1995). Postdoctoral training includes roles at Oak Ridge National Laboratory, University of Rochester, and Yale. Research Interests: Functional MRI (fMRI) advancements, calibrated fMRI for quantitative neural activity, BIRDS molecular imaging (for pH/temperature), and applications in neurodegenerative diseases (e.g., Alzheimer’s) and oncology. Current projects include pH biosensor development, tumor response monitoring, and neuropil density prediction via AI. Awards: Melvin H. Knisely Award, Niels Lassen Award, Lundbeck Visiting Professorship, and fellowships in AIMBE, ARBR, and Sigma Xi. Recently appointed Head of Trumbull College at Yale. Grants: Continuous NIH support across 7 institutes; active projects in molecular imaging, stroke models, and neurovascular coupling. Labs/Teams: MRRC (mrrc.yale.edu), QNMR (qnmr.yale.edu), collaborating with interdisciplinary teams in physics, engineering, and biology.

Kamlesh Khuntiمشاهده پروفایل

استاد

• Diabetes Research
• Vascular Medicine
• Public Health
• +۳ مورد دیگر

Professor Kamlesh Khunti is a globally renowned academic and clinician specializing in Primary Care Diabetes and Vascular Medicine at the University of Leicester. He holds leadership roles as Director of the NIHR Applied Research Collaborations (ARC) East Midlands, Director of the Centre for Ethnic Health Research, and Director of The Real World Evidence Unit. He is also an Honorary Visiting Professorial Fellow at the University of Melbourne's Department of General Practice. His research focuses on diabetes management, ethnic health disparities, pandemic response (including his role in SAGE's Ethnicity Sub-panel during the COVID-19 pandemic), and cardiometabolic disease comorbidities. He has published over 1,100 peer-reviewed articles and been recognized with prestigious awards, including the CBE for services to healthcare. Key research interests include diabetes remission strategies, chronic kidney disease prevention, and optimizing care for populations with multiple long-term conditions. He advocates for equity-focused healthcare policies and has contributed to global guidelines such as KDIGO's Diabetes Management in Chronic Kidney Disease. Professor Khunti's work spans clinical trials, public health interventions, and policy development, with a strong emphasis on addressing health inequities through data-driven approaches. He leads large-scale initiatives like the Embedding research programme to improve diabetes self-management education.

Emiel van der Vorstمشاهده پروفایل

پژوهشگر

• Cardiovascular Research
• Atherosclerosis
• Immunology
• +۶ مورد دیگر

Dr. Emiel van der Vorst is a cardiovascular researcher focusing on atherosclerosis, immunometabolism, and translational medicine . His work spans molecular mechanisms, therapeutic targeting, and omics-based approaches. Affiliation: Institute for Molecular Cardiovascular Research (IMCAR) Research Focus: Chemokine signaling, microRNA therapeutics, immune-metabolic interactions Research Trends: Recent publications highlight his exploration of microRNA-26b in metabolic liver disease GPR55 receptor in cardiomyocyte adaptation calcium-sensing receptor in sex-specific atherosclerosis aryl hydrocarbon receptor in gut-liver-cardiovascular axis His work integrates nanomedicine, genetic models, and clinical biomarker development .

Zoltán Péter Jakusمشاهده پروفایل

دانشیار

• Organ-specific lymphatic vessel development and function
• Molecular mechanisms of autoimmune arthritis development
• Signaling mechanisms of phagocytic cells

Dr. Zoltán Péter Jakus serves as Associate Professor and Head of the Neurophysiology Research Group at the Department of Physiology, School of Medicine, Semmelweis University, Budapest. Affiliated with the institution since 1998, he progressed from student member to research group leader (2014-2017) before attaining his current position in 2017, with an additional research period at the University of Pennsylvania's Cardiovascular Institute (2010-2014). His academic credentials include: MD (Summa cum laude, 2002) from Semmelweis University Faculty of General Medicine PhD (Summa cum laude, 2006) in Molecular and Cellular Physiology from Semmelweis University Research spans three interconnected domains: organ-specific lymphatic vessel biology (2010-present), autoimmune arthritis pathogenesis (2007-present), and phagocytic cell signaling mechanisms (1998-present). This work bridges immunology, vascular biology, and molecular physiology, revealing critical pathways in neutrophil function and lymphatic development with translational implications for inflammatory diseases. Honors include 28 major scientific recognitions reflecting sustained excellence: Habilitation at Semmelweis University (2023) Two Merit Awards from Semmelweis University (2023, 2016) Consecutive Bolyai Research Scholarships from the Hungarian Academy of Sciences (2022, 2007-2010) Junior Prima Prize in Hungarian Science (2011) Multiple publication awards including Faculty of 1000 Highlight (2009) and Nature Signaling Gateway recognition (2006) Mentorship achievements encompass guiding 24 scientific student circle (TDK) participants who earned 32 awards at university/national conferences, plus two PhD graduates (Bálint László 2020, Szőke Dániel 2023). He serves as reviewer for 15+ journals including Blood and Nature Nanotechnology , and evaluates research proposals for national/international funding bodies. His Neurophysiology Research Group integrates molecular, cellular, and in vivo approaches to investigate lymphatic vessel development and autoimmune mechanisms, maintaining active collaborations within European vascular biology networks.

• Surgical Research
• Pancreatic Surgery
• Islet Transplantation
• +۵ مورد دیگر

Gregory Beilman is a Professor in the Department of Surgery and Adjunct Professor in the Department of Anesthesiology at the University of Minnesota Medical School. He holds the Owen H and Sarah Davidson Wangensteen Chair of Surgical Research and serves as the Associate Dean of DoD Research and Partnerships. University of Minnesota Medical School Departments of Surgery and Anesthesiology Specializes in surgical research, diabetes management, and critical care medicine Dr. Beilman’s research focuses on total pancreatectomy with islet autotransplantation (TPIAT) for chronic pancreatitis, including long-term diabetes outcomes, metabolic stress, and pain management. His work also explores hemodynamic monitoring in critical care, trauma surgery outcomes, and HIV immunology. Recent publications highlight clinical trials on TPIAT efficacy, biomarkers for islet graft failure, and EMS training impacts. He has contributed to international consensus guidelines on chronic pancreatitis management. As a leader in surgical research, Dr. Beilman collaborates with the Prospective Observational Study of TPIAT (POST) consortium and has pioneered studies on bioburden reduction in islet isolation.

Terhi Hannele Kärpänenمشاهده پروفایل

مدرس

• Molecular Biology
• Functional Genetics
• Developmental Biology
• +۵ مورد دیگر

Terhi Hannele Kärpänen serves as a Lecturer at Nord University, where she teaches Molecular Cell Biology (BI210F) and actively supervises graduate research. Her academic foundation includes a PhD in Biomedical Sciences from the University of Helsinki (2006), establishing her expertise in molecular and developmental biology. Education: PhD in Biomedical Sciences, University of Helsinki, Finland (2006) Research Focus: Dr. Kärpänen's work centers on molecular regulation of early embryonic development through small regulatory RNAs, with significant contributions to lymphangiogenesis and cancer biology. Her competence spans lymphatic tumor metastasis, lymphedema mechanisms, and cancer immunotherapy development. She employs zebrafish models and molecular genetics to investigate vascular development pathways, particularly VEGF-C/VEGFR-3 signaling and lymphatic vessel formation. Publication Landscape: Her 15 most recent publications (2023-2008) reveal consistent focus on lymphatic system biology, with increasing emphasis on immunotherapy applications. Key trends include molecular dissection of VEGF-C activation mechanisms, genetic regulation of embryonic lymphangiogenesis, and translational T-cell receptor therapies for leukemia. Her work bridges basic developmental biology with oncological applications, frequently utilizing zebrafish models for in vivo validation. Academic Mentorship: Dr. Kärpänen has supervised 1 BSc and 4 MSc theses, demonstrating commitment to undergraduate and master's education. She currently co-supervises 3 PhD students, indicating active engagement in doctoral training and research leadership within her specialized fields.